1. Home
  2. OSIS vs XENE Comparison

OSIS vs XENE Comparison

Compare OSIS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • XENE
  • Stock Information
  • Founded
  • OSIS 1987
  • XENE 1996
  • Country
  • OSIS United States
  • XENE Canada
  • Employees
  • OSIS N/A
  • XENE N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • XENE Health Care
  • Exchange
  • OSIS Nasdaq
  • XENE Nasdaq
  • Market Cap
  • OSIS 2.8B
  • XENE 3.3B
  • IPO Year
  • OSIS 1997
  • XENE 2014
  • Fundamental
  • Price
  • OSIS $166.56
  • XENE $38.52
  • Analyst Decision
  • OSIS Strong Buy
  • XENE Strong Buy
  • Analyst Count
  • OSIS 5
  • XENE 7
  • Target Price
  • OSIS $179.00
  • XENE $56.00
  • AVG Volume (30 Days)
  • OSIS 180.7K
  • XENE 424.9K
  • Earning Date
  • OSIS 01-23-2025
  • XENE 02-27-2025
  • Dividend Yield
  • OSIS N/A
  • XENE N/A
  • EPS Growth
  • OSIS 41.23
  • XENE N/A
  • EPS
  • OSIS 7.68
  • XENE N/A
  • Revenue
  • OSIS $1,603,555,000.00
  • XENE N/A
  • Revenue This Year
  • OSIS $11.52
  • XENE N/A
  • Revenue Next Year
  • OSIS $5.19
  • XENE $1,600.08
  • P/E Ratio
  • OSIS $21.68
  • XENE N/A
  • Revenue Growth
  • OSIS 24.35
  • XENE N/A
  • 52 Week Low
  • OSIS $126.25
  • XENE $35.53
  • 52 Week High
  • OSIS $189.13
  • XENE $50.99
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 49.99
  • XENE 42.98
  • Support Level
  • OSIS $150.84
  • XENE $36.90
  • Resistance Level
  • OSIS $168.20
  • XENE $41.03
  • Average True Range (ATR)
  • OSIS 4.88
  • XENE 1.41
  • MACD
  • OSIS -0.35
  • XENE 0.03
  • Stochastic Oscillator
  • OSIS 61.45
  • XENE 30.39

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: